Rehabilitation in Severely Ill Inpatients With COVID-19
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19
- Status
- COMPLETED
- Phase
- N/A
Hypertonic Saline Nasal Irrigation and Gargling (HSNIG) for Suspected COVID-19 in Pakistan
- Status
- UNKNOWN
- Phase
- NA
COVID-19 Quantitative Antibody Titers & Booster Vaccinations
- Status
- COMPLETED
- Phase
- N/A
Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD
- Status
- UNKNOWN
- Phase
- PHASE4
Study of COVID-19 Prognostic Factors in Hospitalized Patients
- Status
- COMPLETED
- Phase
- N/A
The Effect of Listening to Music During CPAP on the Agitation Levels and Compliance.
- Status
- COMPLETED
- Phase
- NA
Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran
- Status
- UNKNOWN
- Phase
- N/A
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
- Status
- COMPLETED
- Phase
- N/A
Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
- Status
- COMPLETED
- Phase
- N/A
PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
National Vaccine Adverse Event Reporting Survey and Etiology
- Status
- UNKNOWN
- Phase
- N/A
Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
- Status
- UNKNOWN
- Phase
- PHASE4
Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).
- Status
- COMPLETED
- Phase
- N/A
Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.
- Status
- UNKNOWN
- Phase
- NA
Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol
- Status
- COMPLETED
- Phase
- PHASE1
Prognostic Value of IgM in Covid-19 Infection
- Status
- UNKNOWN
- Phase
- N/A
COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19
- Status
- TERMINATED
- Phase
- PHASE1
Psychological Impact of COVID-19 on Intensive Care Survivors
- Status
- COMPLETED
- Phase
- N/A